Clinical Trial Update: Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial evaluating lenalidomide in combination with oral dexamethasone for previously untreated, symptomatic chronic lymphocytic leukemia; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED